Ad is loading...
ANNX
Price
$6.12
Change
-$0.21 (-3.32%)
Updated
Nov 15 closing price
123 days until earnings call
DNTH
Price
$23.36
Change
-$2.13 (-8.36%)
Updated
Nov 15 closing price
Ad is loading...

ANNX vs DNTH

Header iconANNX vs DNTH Comparison
Open Charts ANNX vs DNTHBanner chart's image
Annexon
Price$6.12
Change-$0.21 (-3.32%)
Volume$1.92M
CapitalizationN/A
Dianthus Therapeutics
Price$23.36
Change-$2.13 (-8.36%)
Volume$627.82K
CapitalizationN/A
ANNX vs DNTH Comparison Chart
Loading...
ANNX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
DNTH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ANNX vs. DNTH commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANNX is a Sell and DNTH is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (ANNX: $6.12 vs. DNTH: $23.36)
Brand notoriety: ANNX and DNTH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANNX: 134% vs. DNTH: 233%
Market capitalization -- ANNX: $646.6M vs. DNTH: $691.39M
ANNX [@Biotechnology] is valued at $646.6M. DNTH’s [@Biotechnology] market capitalization is $691.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANNX’s FA Score shows that 1 FA rating(s) are green whileDNTH’s FA Score has 0 green FA rating(s).

  • ANNX’s FA Score: 1 green, 4 red.
  • DNTH’s FA Score: 0 green, 5 red.
According to our system of comparison, ANNX is a better buy in the long-term than DNTH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANNX’s TA Score shows that 4 TA indicator(s) are bullish while DNTH’s TA Score has 6 bullish TA indicator(s).

  • ANNX’s TA Score: 4 bullish, 6 bearish.
  • DNTH’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, DNTH is a better buy in the short-term than ANNX.

Price Growth

ANNX (@Biotechnology) experienced а -15.35% price change this week, while DNTH (@Biotechnology) price change was -19.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

ANNX is expected to report earnings on Mar 20, 2025.

DNTH is expected to report earnings on Nov 09, 2023.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNTH($691M) has a higher market cap than ANNX($647M). DNTH YTD gains are higher at: 124.615 vs. ANNX (34.802). DNTH has higher annual earnings (EBITDA): -68.36M vs. ANNX (-124.62M). ANNX (369M) and DNTH (361M) have equal amount of cash in the bank . DNTH has less debt than ANNX: DNTH (407K) vs ANNX (30.2M). DNTH has higher revenues than ANNX: DNTH (4.12M) vs ANNX (0).
ANNXDNTHANNX / DNTH
Capitalization647M691M94%
EBITDA-124.62M-68.36M182%
Gain YTD34.802124.61528%
P/E RatioN/A3.24-
Revenue04.12M-
Total Cash369M361M102%
Total Debt30.2M407K7,420%
FUNDAMENTALS RATINGS
DNTH: Fundamental Ratings
DNTH
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
37
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
78
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANNXDNTH
RSI
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
85%
Bullish Trend 11 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
85%
Aroon
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
89%
View a ticker or compare two or three
Ad is loading...
ANNX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
DNTH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IVFIX3.75N/A
N/A
Federated Hermes Intl Strat Val Div IS
FESRX10.89-0.12
-1.09%
First Eagle Small Cap Opportunity R6
WIMVX11.94-0.14
-1.16%
Segall Bryant & Hamill Glb All Cp Inst
OTIIX66.06-0.96
-1.43%
T. Rowe Price Small-Cap Stock I
BHCHX19.97-0.58
-2.82%
Baron Health Care Instl

ANNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANNX has been loosely correlated with MGTX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ANNX jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANNX
1D Price
Change %
ANNX100%
-3.32%
MGTX - ANNX
43%
Loosely correlated
-2.41%
FDMT - ANNX
40%
Loosely correlated
+10.10%
FULC - ANNX
40%
Loosely correlated
-9.49%
DNTH - ANNX
40%
Loosely correlated
-8.36%
ERAS - ANNX
39%
Loosely correlated
-4.98%
More

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with ANNX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then ANNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
-8.36%
ANNX - DNTH
40%
Loosely correlated
-3.32%
IMNM - DNTH
37%
Loosely correlated
-11.09%
MGTX - DNTH
36%
Loosely correlated
-2.41%
ATXS - DNTH
34%
Loosely correlated
-7.14%
PRTA - DNTH
30%
Poorly correlated
-12.98%
More